Incidental Mutation 'R1211:Gm10160'
ID 100689
Institutional Source Beutler Lab
Gene Symbol Gm10160
Ensembl Gene ENSMUSG00000066378
Gene Name predicted gene 10160
Synonyms
MMRRC Submission 039280-MU
Accession Numbers
Essential gene? Not available question?
Stock # R1211 (G1)
Quality Score 182
Status Not validated
Chromosome 7
Chromosomal Location 81505281-81505542 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to T at 81505497 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Tyrosine to Asparagine at position 16 (Y16N)
Ref Sequence ENSEMBL: ENSMUSP00000082175 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000041890] [ENSMUST00000085094] [ENSMUST00000126334]
AlphaFold F6Y577
Predicted Effect probably benign
Transcript: ENSMUST00000041890
SMART Domains Protein: ENSMUSP00000038017
Gene: ENSMUSG00000038623

DomainStartEndE-ValueType
transmembrane domain 5 27 N/A INTRINSIC
transmembrane domain 32 54 N/A INTRINSIC
transmembrane domain 63 82 N/A INTRINSIC
transmembrane domain 110 132 N/A INTRINSIC
transmembrane domain 139 161 N/A INTRINSIC
transmembrane domain 167 189 N/A INTRINSIC
Pfam:DUF2781 217 356 6.9e-23 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000085094
AA Change: Y16N

PolyPhen 2 Score 0.002 (Sensitivity: 0.99; Specificity: 0.30)
Predicted Effect noncoding transcript
Transcript: ENSMUST00000124616
Predicted Effect probably benign
Transcript: ENSMUST00000126334
SMART Domains Protein: ENSMUSP00000121292
Gene: ENSMUSG00000038623

DomainStartEndE-ValueType
transmembrane domain 5 27 N/A INTRINSIC
transmembrane domain 32 54 N/A INTRINSIC
transmembrane domain 63 82 N/A INTRINSIC
transmembrane domain 110 132 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000134861
Predicted Effect noncoding transcript
Transcript: ENSMUST00000207657
Coding Region Coverage
  • 1x: 99.3%
  • 3x: 98.2%
  • 10x: 95.3%
  • 20x: 89.2%
Validation Efficiency
Allele List at MGI
Other mutations in this stock
Total: 15 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adgra3 T C 5: 50,164,218 (GRCm39) M254V possibly damaging Het
Arrdc3 A G 13: 81,038,817 (GRCm39) T40A possibly damaging Het
Cntnap1 C A 11: 101,075,536 (GRCm39) Q905K probably damaging Het
Dclk1 A G 3: 55,288,244 (GRCm39) I256V probably benign Het
Dync1h1 G A 12: 110,602,943 (GRCm39) E2195K probably benign Het
Erlec1 A G 11: 30,898,298 (GRCm39) probably null Het
Gm10608 C CNNNNNNNN 9: 118,989,780 (GRCm39) probably null Het
H2-T13 A T 17: 36,391,965 (GRCm39) V207D probably damaging Het
Kcna4 AGAGGAGGAGGAGGAGGAGG AGAGGAGGAGGAGGAGG 2: 107,125,660 (GRCm39) probably benign Het
Mycbp2 A T 14: 103,357,999 (GRCm39) D4488E probably benign Het
Ndufaf1 A G 2: 119,486,156 (GRCm39) S319P probably damaging Het
Or5h25 A C 16: 58,930,523 (GRCm39) V150G possibly damaging Het
Smad4 T C 18: 73,782,982 (GRCm39) probably null Het
Spaca7 T C 8: 12,623,139 (GRCm39) S12P probably damaging Het
Stx11 A G 10: 12,817,155 (GRCm39) S190P probably damaging Het
Predicted Primers PCR Primer
(F):5'- TTGCCACAGTGTATCCCACAGAAC -3'
(R):5'- TGACCCAGAGCCTCACTCAACTTAG -3'

Sequencing Primer
(F):5'- cctcctcctcctcctcctc -3'
(R):5'- TTTGAGAGAGGGACAAATTCTGC -3'
Posted On 2014-01-15